Concepedia

Aric Huang

AH

Statistics

Publications

12

Citations

417

H-Index

11

Active since

2015

Affiliations

University of Kansas(Current)

Thrombosis and Atherosclerosis Research Institute

McMaster University

Frederick National Laboratory for Cancer Research

National Institute of Allergy and Infectious Diseases

Aric Huang is an author at University of Kansas specializing in life sciences, atherosclerosis molecular mechanisms, and pharmacology.

ORCID

Publications per year

2015–2022

12

Publications

12

Formulation and preclinical evaluation of a toll-like receptor 7/8 agonist as an anti-tumoral immunomodulator

Ruolin Lu, Chad E. Groer, Peter A. Kleindl et al. · Journal of Controlled Release · 2019 · 86 citations · Full text

, , +17

Comprehensive Plasma Metabolomic Analyses of Atherosclerotic Progression Reveal Alterations in Glycerophospholipid and Sphingolipid Metabolism in Apolipoprotein E-deficient Mice

Vi T. Dang, Aric Huang, Lexy H. Zhong et al. · Scientific Reports · 2016 · 79 citations · Full text

, , +12

4-phenylbutyrate and valproate treatment attenuates the progression of atherosclerosis and stabilizes existing plaques

Aric Huang, Tayler L. Young, Vi T. Dang et al. · Atherosclerosis · 2017 · 46 citations

, , +12

Glycosphingolipids promote pro-atherogenic pathways in the pathogenesis of hyperglycemia-induced accelerated atherosclerosis

Vi T. Dang, Lexy H. Zhong, Aric Huang et al. · Metabolomics · 2018 · 40 citations

, , +14

Deletion of Myeloid GSK3α Attenuates Atherosclerosis and Promotes an M2 Macrophage Phenotype

Cameron S. McAlpine, Aric Huang, Abby Emdin et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2015 · 32 citations

, , +17

1–5 of 12